1. Home
  2. CSBR vs CLAR Comparison

CSBR vs CLAR Comparison

Compare CSBR & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • CLAR
  • Stock Information
  • Founded
  • CSBR 1985
  • CLAR 1957
  • Country
  • CSBR United States
  • CLAR United States
  • Employees
  • CSBR N/A
  • CLAR N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • CLAR Recreational Games/Products/Toys
  • Sector
  • CSBR Health Care
  • CLAR Consumer Discretionary
  • Exchange
  • CSBR Nasdaq
  • CLAR Nasdaq
  • Market Cap
  • CSBR 123.2M
  • CLAR 139.4M
  • IPO Year
  • CSBR 1986
  • CLAR N/A
  • Fundamental
  • Price
  • CSBR $6.42
  • CLAR $3.40
  • Analyst Decision
  • CSBR Strong Buy
  • CLAR Strong Buy
  • Analyst Count
  • CSBR 1
  • CLAR 3
  • Target Price
  • CSBR $12.00
  • CLAR $5.33
  • AVG Volume (30 Days)
  • CSBR 40.7K
  • CLAR 104.6K
  • Earning Date
  • CSBR 09-15-2025
  • CLAR 11-06-2025
  • Dividend Yield
  • CSBR N/A
  • CLAR 2.92%
  • EPS Growth
  • CSBR N/A
  • CLAR N/A
  • EPS
  • CSBR 0.21
  • CLAR N/A
  • Revenue
  • CSBR $56,878,000.00
  • CLAR $254,200,000.00
  • Revenue This Year
  • CSBR $9.30
  • CLAR N/A
  • Revenue Next Year
  • CSBR $31.17
  • CLAR $4.38
  • P/E Ratio
  • CSBR $29.53
  • CLAR N/A
  • Revenue Growth
  • CSBR 10.11
  • CLAR N/A
  • 52 Week Low
  • CSBR $3.75
  • CLAR $3.02
  • 52 Week High
  • CSBR $11.99
  • CLAR $5.29
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 46.30
  • CLAR 39.14
  • Support Level
  • CSBR $6.27
  • CLAR $3.35
  • Resistance Level
  • CSBR $6.90
  • CLAR $3.80
  • Average True Range (ATR)
  • CSBR 0.29
  • CLAR 0.15
  • MACD
  • CSBR -0.02
  • CLAR -0.04
  • Stochastic Oscillator
  • CSBR 23.37
  • CLAR 11.67

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.

Share on Social Networks: